The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC

Condition:   Hepatitis B Interventions:   Drug: Peginterferon Alfa-2A;   Drug: Adefovir, entecavir,tenofovir, either of them Sponsor:   Shanghai Nanhui Nanhua Hospital Active, not recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials